Mind Medicine (MNMD) said Thursday that it is set to join the Nasdaq Biotechnology Index on Monday.
Companies are selected annually in December for the Nasdaq Biotechnology Index based on specific eligibility criteria, including their classification as biotechnology or pharmaceutical companies under the Industry Classification Benchmark, according to Mind Medicine.
Price: 7.24, Change: +0.01, Percent Change: +0.14